These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3047990)

  • 1. [Effect of obsidan and labetalol on the course of myocardial infarction].
    Sirenko IuN; Mironova OV; Ivanova DK; Shkliar LV
    Vrach Delo; 1988 Jun; (6):20-3. PubMed ID: 3047990
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of labetalol and propranolol in patients who have had a myocardial infarct].
    Il'iash MG; Kravtsova LA; Babov KD; Shcherbak IaIu
    Vrach Delo; 1990 May; (5):26-8. PubMed ID: 2396387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure.
    Pinelli A; Trivulzio S; Tomasoni L; Brenna S; Bonacina E; Accinni R
    Eur J Pharm Sci; 2004 Nov; 23(3):277-85. PubMed ID: 15489129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of the effect of obsidan on the clinical picture of myocardial infarction at the early stage of the disease].
    Andriushchenko OM
    Klin Med (Mosk); 1989 Oct; 67(10):48-51. PubMed ID: 2615306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of labetalol on hemodynamics and oxygen consumption in patients in the early period of myocardial infarction].
    Gvatua NA; Mironova OV; Sirenko IuN; Tolstopiatov SM
    Kardiologiia; 1990 Apr; 30(4):30-3. PubMed ID: 2203928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
    Ivanova LK
    Vrach Delo; 1980 Oct; (10):15-8. PubMed ID: 6108019
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of obsidan on the content of catecholamines and renin in the blood in myocardial infarct].
    Simerzin VV
    Sov Med; 1988; (11):59-62. PubMed ID: 3070784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of obsidan in different hemodynamic variants of acute myocardial infarction].
    Netiazhenko VZ; Parkhomenko AN
    Vrach Delo; 1986 Jan; (1):12-5. PubMed ID: 3953032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
    Erina EV; Charyev KhE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):26-34. PubMed ID: 6139117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Propranolol (Inderal) in acute myocardial infarct].
    Nielsen BL; Jorgensen FS; Clausen J; Felsby M; Roin J; Strange B
    Ugeskr Laeger; 1967 May; 129(21):689-96. PubMed ID: 4877646
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of adrenergic beta receptor blockaders in myocardial infarct].
    Florkiewicz H; Rymar B; Przegaliński J; Markiewicz M
    Pol Tyg Lek; 1980 Jun; 35(23):853-5. PubMed ID: 6997844
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of obsidan in patients with myocardial infarction].
    Dobrotvorskaia TE; Mustafaev FM; Arifullin ShS
    Kardiologiia; 1989 Jun; 29(6):71-5. PubMed ID: 2779085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmarketing comparison of labetalol and propranolol in hypertensive patients.
    Due DL; Giguere GC; Plachetka JR
    Clin Ther; 1986; 8(6):624-31. PubMed ID: 3791361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
    Hawkins CM; Richardson DW; Vokonas PS
    Circulation; 1983 Jun; 67(6 Pt 2):I94-7. PubMed ID: 6342843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nitrates and obsidan on myocardial infarction].
    Malinovskaia IE; Ivanova LK; Shkliar LV
    Vrach Delo; 1985 Jan; (1):56-9. PubMed ID: 3920832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.